Addenbrooke's Charitable Trust Logo
Close
Menu

Tag: cancer

New Treatment Approach Shows Promise for Aggressive Breast Cancers 

Posted on by Paul White

A ground-breaking trial, funded with the help of ACT supporters, has led to a significant improvement in survival rates for patients with aggressive, inherited breast cancers. Cambridge researchers have discovered that a new treatment approach, involving chemotherapy followed by a targeted cancer drug before surgery, has resulted in a 100% survival rates for patients who took part in a trial three years post-surgery.

Published today in the journal Nature Communications, this discovery could become the most effective treatment to date for early-stage breast cancer patients with inherited BRCA1 and BRCA2 gene mutations. These types of breast cancers are notoriously difficult to treat, gaining public attention when actress Angelina Jolie, a BRCA1 carrier, underwent a preventative double mastectomy in 2013.

The current standard treatment aims to shrink the tumour using chemotherapy and immunotherapy before removing the tumour through surgery. However, the first three years after surgery are critical, with the highest risk of relapse after death. The Partner trial took a different approach, demonstrating two key innovations: the addition of olaparib and chemotherapy pre-surgery, and the benefits of careful timing of treatments. Olaparib, a targeted cancer drug taken as tablets, is already available on the NHS.

Led by Addenbrooke’s Hospital, part of Cambridge University Hospitals (CUH) NHS Foundation Trust and the University of Cambridge, the trial recruited patients from 23 NHS sites across the UK. Results show that leaving a 48-hour gap between chemotherapy and olaparib leads to better outcomes, possibly because the patient’s bone marrow has time to recover from chemotherapy while leaving the tumour cells susceptible to the targeted drug. Of the 39 patients who received chemotherapy followed by olaparib only one relapsed three years after surgery, and 100% survived. In comparison, the survival rate for the control arm was 88% three years after surgery.

Jackie Van Bochoven, a 59-year-old from South Cambridgeshire, was diagnosed in February 2019 with a small but aggressive tumour. She shared her experience: “When I had the diagnosis, I was completely shocked and numb. I thought about my children, and my mum and sister who were diagnosed with breast cancer. I was pretty worried. Six years on, I’m well and cancer-free. I’m back at work, enjoying life and spending time with my family. When you’ve had cancer, I think you look at life differently and every day is a bonus”.

Patient Jackie Van Bochoven (second left) and her daughters – Danielle, Charlotte and Jocelyn (L to R)
Copyright: Cambridge University Hospitals

The findings have the potential to be applied to other cancers caused by faulty copies of the BRCA genes, such as some ovarian, prostate, and pancreatic cancers. It may also have cost-saving benefits for the NHS, as patients currently offered olaparib take the drug post-surgery for 12 months, whereas patients on the trial took the tablets pre-surgery for 12 weeks.

Professor Jean Abraham, Addenbrooke’s Hospital.
Copyright: Stillvision photography

Professor Jean Abraham, Addenbrooke’s consultant and trial lead, expressed excitement about the potential of this new approach: “It is rare to have a 100% survival rate in a study like this and for these aggressive types of cancer. We’re incredibly excited about the potential of this new approach, as its crucial that we find a way to treat and hopefully cure patients who are diagnosed with BRCA1 and BRCA2 related cancers”.

Shelly Thake, CEO of Addenbrooke’s Charitable Trust, which supported the Partner trial with funding from our kind supporters, said: “One of the greatest privileges we have as a charity is supporting transformative, pioneering and radical people. The finest minds in their fields whose research is shaping the future of healthcare, doing things differently so that we can stop people suffering from cancers we should be beating. Jean is one of those individuals, and her work developing personalised breast cancer treatments remains one of the most powerful examples of what ACT – and the wonderful people who donate to ACT – can make possible. This news gives hope to countless women who live with the fear of aggressive, inherited breast cancers. It is also a profound example of what the new Cambridge Cancer Research Hospital that we are currently fundraising for will make possible, and why there is nowhere else other than Cambridge where this hospital would be possible with its critical mass of clinicians, researchers, world-class hospitals and pioneering organisations such as the University and pharmaceutical companies”.

ACT supported Professor Abraham by funding her salary for two years, which enabled her to work on multiple breast cancer projects.

“That kind of support at that stage is a boost in that it gives you the feeling that someone believes in what you are doing. It is always good to get someone else to verify that your ideas are sound, and if people back it with money then that’s a very big statement of support. So, from my perspective, having ACT’s funding to support me was a very visible and real sign of the belief in my abilities and there’s no price you can put on that kind of confidence at that stage in your career.”

“Probably the most undervalued quality in science and medicine is determination and persistence because this wasn’t straight forward. We went to more than one drug company to get a drug; we didn’t always get the funding that we should have got and there have been a lot of hurdles.

We had to get through COVID – there’s been a lot that has happened. Some of the firms that were doing the work of testing went bust. A lot happens when you are trying to deliver a trial, so for anyone who is more junior and is thinking of a career as a clinical trialist or clinical academic, I would say, obviously you have to be smart and have general ideas, but fundamentally you have to be determined, persistent and not let other people’s inability to see what you see stop you. To have that belief in yourself and your team and to take the project forward I think is really important.”

Mark O’Connor, chief scientist in Early Oncology R&D at AstraZeneca, added: “The Partner trial highlights the importance of detecting and treating cancer early, and the value of innovative science in informing clinical trial design. While the findings need to be validated in a larger study, they’re incredibly exciting and have the potential to transform outcomes for patient populations who have unmet clinical needs”.

This collaboration between NHS, academia, and industry, reflects the vision of the Cambridge Cancer Research Hospital, a specialist cancer research hospital due to be built on Europe’s leading life sciences campus, the Cambridge Biomedical Campus. It will bring clinical expertise from Addenbrooke’s Hospital together with world-class scientists from the University of Cambridge, Cancer Research UK Cambridge Centre, and industry partners to create new diagnostics and treatments to detect the earliest signs of cancer and deliver personalised, precision medicine.

Michelle Mitchell, Chief Executive of Cancer Research UK, commented: “One of the best ways that we can beat cancer sooner is by making more effective use of treatments that are already available to us. While this research is still in its infancy, it is an exciting discovery that adding olaparib at a carefully-timed stage of treatment can potentially give patients with this specific type of breast cancer more time with their loved ones. Research like this can help find safer and kinder ways to treat certain types of cancer. Further studies in more patients are needed to confirm whether this new technique is safe and effective enough to be used by the NHS”.

Professor Abraham and the team are now planning the next phase of the research, which will look to replicate the results in a larger study and confirm that the Partner approach offers a less toxic treatment for patients as well as being more cost-effective to the current standard of care. She said:

“All jobs have their moments. The privilege I have is that you are always grounded by your patients because no matter how tough you think you are having it, you know that your patients are having it a great deal tougher. And actually, the thing that should motivate you is not whether you can get an H paper or an H Comms paper (a metric used to measure the productivity and impact of a researcher’s publications), both of which we got, but actually it’s ‘will it make a difference to the people that you see every week in clinic?’ that should be your driver.”

The Partner trial was sponsored by Cambridge University Hospitals (CUH) NHS Foundation Trust and the University of Cambridge, funded by Cancer Research UK and AstraZeneca, and supported by Addenbrooke’s Charitable Trust (ACT), the NIHR Cambridge Biomedical Research Centre, and the Cancer Research UK Cambridge Centre.

Former cancer patient to run sixty miler from Swavesey to Spurs ground to raise funds for Addenbrooke’s cancer services

Posted on by Danni Smith

A former cancer patient who has spent over twenty years completing challenges after being given the all-clear following his testicular cancer diagnosis is now set to complete his latest challenge – an ‘ultra’ 62 mile-run from his home in Swavesey in Cambridgeshire to the football grounds of Tottenham Hotspur in London. 

Sean Papworth, 50, an avid Spurs fan, will complete what he is calling the ‘Swavesey to Spurs SIXTY Miler’ with his godson Max Rose, 22, an avid Liverpool fan – with both men intending to cross the finishing line in each of their team’s strip. 

Setting off from The Green in Swavesey on Saturday 26th April, the pair – who only recently completed the Cambridge Half Marathon – will not only cross the line in two different football strips but will arrive a day before the two Premier League Teams are set to play each other.  

Covering a total of 62 miles, Sean and Max will follow a route running along paths and through villages parallel to the A10. Friends and family will follow in a support vehicle with others on bikes. Setting off at six in the morning, with just a few stops along the way for food, the pair are expected to take between 12 and 15 hours to reach their destination.  

Describing the ultra as ‘unchartered territory in running’ for him, Sean said; “I am going to have to dig deep to achieve this. It’s going to be a tough run. Just training doing 19 miles, I can feel it in my legs.” 

Sean, who has completed numerous fundraising challenges since being given the all-clear from testicular cancer 20 years ago, is hoping to raise over two and a half thousand pounds for Addenbrooke’s Charitable Trust as well as mental health charity Mind, as a way of thanking staff at Addenbrooke’s who treated both him, and his dad, who sadly died from bowel cancer when Sean was just 12 years old. 

Addenbrooke’s Charitable Trust (ACT) is the official charity for Addenbrooke’s Hospital and the Rosie and funds cutting-edge equipment, groundbreaking research, and improvements to the environment for both staff and patients, above and beyond what the NHS is able to provide. 

Sean was diagnosed with testicular cancer back in 2003 when he was just 28. He had two baby girls at the time and, as a joiner, had just set up his business making staircases. He said his wife, Kelly, had to bring the girls up while he was undergoing treatment, which involved surgery followed by intense rounds of chemo. His cancer then spread and surgeons had to cut open his stomach to remove a lot of lymph nodes.  

He was given the all-clear a year later and went on to have a boy, completing his family of three: his eldest daughter Nevie, now 25; middle daughter Teagan, 22, and son Dexter, 18. 

But despite his own battle with cancer, Sean said it was losing his dad from bowel cancer when he was just 12 years old that left the biggest imprint on his life. 

He says the nod to mental health is his acknowledgement of how tough it was to lose his dad. He says while he can talk very openly about his own cancer, he found it really hard to talk about his dad growing up, and counselling later in life really helped him. 

“My dad had bowel cancer and it was very quick. I remember him being ill in the September and him coming out of hospital in the December. I remember my mum telling me it was terminal and that he had come home because he didn’t want to be in hospital when he died and then we lost him in the January.”

“As much as my cancer was hard, the toughest thing I’ve ever had to go through was losing my dad.”

“I used to clam up about my dad especially. I think because I was such a young age. But then I had some counselling, when I was about 20, and then some more a couple of years ago. As the years have gone by, I’ve talked about it but at the same time put a bit of a brave face on and just sort of taken it in my stride rather than actually going, ‘that was quite a big thing that happened to me.”

Describing cancer as a ‘horrible, cruel disease’, Sean says he had to turn to counselling again more recently after reaching middle age and losing other friends to cancer as well as a close friend to suicide last year. 

“I just think when you get to this age you evaluate things a lot more. I had a couple of years where everything was happening at once and it sort of took its toll.” 

Since his recovery Sean has set himself numerous challenges including biking from the UK to Sweden; completing Lands End to John o’Groats; running the London Marathon last year and the Cambridge Half Marathon this year, along with the 2025 Paris Marathon – with the grand finale (for now!) the ‘Swavesey to Spurs SIXTY Miler’.  

Sean says all of the challenges he has set himself are a nod to those who have not made it through their treatment and says: “I’m still here and I’m still fine. That’s why I am doing this run, not just to raise money but to prove I can and because I’m alive and just the fact that a lot of people don’t come out of hospital alive.”  

Recalling his time on the ward, Sean says he remembers a 13-year-old being treated for cancer – “which was really humbling” – and a man around his own age, who also had testicular cancer and had the same operation as him.  

“He later died and I remember his wife messaging me to say that they had lost him and that’s why I do everything I do. It’s in memory of all those people who haven’t made it, not the people who do. To me, if you’ve had cancer and got through it then you have to do something good with that.” 

He also remembers his eldest daughter coming to see him in hospital when she was only three.

“I remember seeing her little face coming into the ward. Her face dropped when she saw me, and things like that really stick with you.”

But as hard as his experiences have been, Sean says remembering how lucky he is helps him to keep going.

“Everyone gets low moments in their life and you can’t always snap out of them quickly but when you get into a better place you can tell yourself not to feel sorry for yourself because there are lots of people going through awful things like cancer, including little children. You can have a moan and feel sorry for yourself but that’s the slap on the face you need to keep going.” 

Sean will start the run from his home in Swavesey to Tottenham Hotspur football grounds in an ACT t-shirt but plans to have several t-shirt changes along the way, including a couple of shirts he is having designed with his sponsors’ names on. However, he plans to cross the finishing line in his Tottenham Hotspur shirt. Max – who is the son of his close friend Simon, whose kids have all grown up together – will be wearing his Liverpool strip.  

Asked how he thought they would both manage the run, Sean said: “Max is more than half my age and a lot fitter than me but he’s never done a marathon before so I’ve got that over him because I’ve had that experience. As far as rivalry goes though, it only goes as far as our football teams, not the run. We are going to need to have each others’ backs for this run and be strong for each other.”   

Cambridge is set to have its own cancer research hospital, to be built on the Cambridge Biomedical Campus by 2029. The Cambridge Cancer Research Hospital (CCRH) will be the first specialist cancer hospital for the East of England. It will bring together clinical and research expertise under one roof – allowing clinicians to detect cancer earlier, treat it more precisely and save more lives.

*** Sean will be auctioning off a Tottenham Hotspur pennant signed by some of the current squad – and anyone wanting to donate to his fundraising page, or sponsor him ÂŁ200 for a logo on his running shirts – should go to Sean’s Give Wheel page at: https://www.givewheel.com/fundraising/5937/sean  

Former cancer patient whose pioneering immunotherapy treatment rid his body of the disease urges others to never give up hope

Posted on by Danni Smith

David Bateson, from Bedfordshire, was diagnosed with melanoma in 2019. The father-of-three, from Ampthill, had an operation to remove the lesion, followed by a skin graft. The cancer returned the following year and David needed to have surgery to remove his lymph nodes from his neck, followed by radiotherapy. David was then put on a course of immunotherapy as a preventative measure, but it was on his birthday in 2021, two years later, that he received the news that his cancer had returned, it was Stage 4 and had spread to his liver, lungs and spine. 

“I just thought, it’s Stage 4 and it’s spread to all those organs. I’m done.” 

David’s consultant, Dr Pippa Corrie, a consultant medical oncologist at Addenbrooke’s, prescribed David a new course of immunotherapy treatment, combining two drugs to kick-start his immune system and after two years of the pioneering treatment, David was given the news in January of this year that there was no trace of cancer in his body. 

David said: “I went from believing I was going to die to being told there was no trace of cancer in my body and there was only a 2% chance of it returning. I just feel incredibly lucky and I appreciate life so much. I have a second go at this and it’s just amazing.” 

“The chances are I wouldn’t be here today if it wasn’t for people at the hospital researching and developing new drugs to fight cancer.” 

Research is key at Addenbrooke’s and the wider Cambridge Biomedical Campus. With technical advances in genome sequencing, AI and immunotherapy, patients are experiencing new hope through personalised cancer treatments. This integrated approach will help fast track cancer innovations and will mean patients from not just across the region, but the whole country, can directly benefit from the latest innovations in cancer science.

David is now a member of the hospital’s Patient Advisory Group (PAG), a group of current and former patients using their lived experience to help design and shape the best care to meet everyone’s needs. 

Knowing how lucky he is to be here now, David has this message for other cancer patients. “Don’t ever give up hope. Someone, somewhere, is testing something that could help you. Don’t underestimate the power of medical science and what drugs can do for you.” 

Dr Pippa Corrie, Consultant Medical Oncologist

Dr Corrie, who specialises in melanoma and pancreaticobiliary cancers, said: “Immunotherapy and immune checkpoint inhibitors are really revolutionary in that before 10/15 years ago, people like David really had very little options in terms of treatment and unfortunately very poor outcomes. Now we can offer them effective immunotherapy which can potentially improve their life expectancy and actually cure some people and that’s really a major step change in how we manage patients with melanoma and now we are doing the same by using these drugs to treat other types of cancer as well.” 

David decided to start fundraising for Addenbrooke’s Charitable Trust as soon as he started his immunotherapy treatment, giving himself the goal of raising ÂŁ500 for further investment into this groundbreaking medical technology. He has since exceeded his goal, going on to raise a staggering ÂŁ50,000.  

David’s ÂŁ50,000 fundraising tally was reached with a charity football match and a silent raffle and auction. The football match saw Ampthill Town Football Club battle it out against Luton Town Football Club under 21s (which David’s son Jack plays for). Former England goalkeeper David James made a special appearance on the day. 

Earlier this year, Luton Town’s Mick Harford presented David with a giant cheque for £50,000, made out to ACT, at the City’s Premier League match against Fulham FC, which saw the club relegated after losing 4-2.  

“He’s a bit of a legend for someone my age. It was a hell of a surprise, such a lovely thing to do.” 

Describing what it was like to be told he had Stage 4 cancer that had spread to his major organs, David said: “I was just walking round punch-drunk, like I wasn’t really there.” 

The hardest thing was worrying about what would happen to his family – his wife, Lisa, a community nurse, and their children, George, 22; Jack, 19, and Grace, 17. 

“Having kids is the best feeling in the world. When they are born, the feeling you have is unbelievable. I didn’t want to not be there for them, I kept thinking about all the things I would miss. Things like walking Grace down the aisle.” 

But he said despite how he was feeling, his strategy was to try and ‘normalise’ cancer whenever he was at home. “I just tried to normalise it. That was my strategy. During the time I’ve had cancer, the kids have done their A levels, GCSEs, driving tests, got girlfriends, boyfriends, and I like to think that this cancer hasn’t completely ruined their young lives. And that’s a credit to me and Lisa. How we have set the tone and dealt with it.” 

Despite David’s amazing news in January, Lisa said the emotional scars are still there and said, even now, she finds herself reluctant to celebrate.  

“Even now, with David being told he only has a 2% chance of his cancer returning, I still feel scared to celebrate. We have had so many different celebrations where we have been given good news, I am more sceptical now. I think it’s just a way of protecting myself.” 

For David though – “this time feels different” – and having been given the good news back in January, he is keen to continue fundraising for the hospital.

“I really think in 20 years’ time we will be saying, ‘remember when cancer used to kill us.’ It is all about changing the story of cancer.” 

Cambridge Cancer Research Hospital, courtesy of NBBJ

To find out more about fundraising to support cancer services at Addenbrooke’s, please click here. 

Read more of David’s story and watch his story below.

Congratulations! Two of our fundraisers nominated for this year’s prestigious Pride of Britain Awards

Posted on by Danni Smith

A HUGE thank you and congratulations to two of our fundraisers who featured in a TV special as nominees for this year’s prestigious Pride of Britain Awards.

David Bateson, pictured here with medical oncology consultant Dr Brent O’Carrigan, and Joyce Cripps, pictured with transplant surgeon Andrew Butler, being filmed in the background, have fundraised tirelessly for Addenbrooke’s through Addenbrooke’s Charitable Trust (ACT), the official charity for Addenbrooke’s and the Rosie, whose supporters raise funds to help make the hospitals even better by funding cutting-edge research, innovations and high-tech equipment, above and beyond what the NHS is able to provide.

Both were shortlisted for ITV Anglia’s Regional Fundraiser of the Year and although they weren’t selected to go through to the finals of Pride of Britain Awards later this year, we are incredibly proud of both of them for all their hard work and for sharing their personal stories to a wider audience.

David Bateson – who has raised £50,000 for Addenbrooke’s Charitable Trust after being treated at Addenbrooke’s Hospital for cancer – shared his story on the ITV Anglia special.

The father of three, from Ampthill in Bedfordshire, was diagnosed with melanoma in 2019. David’s cancer returned twice but after surgery and treatment, followed by pioneering immunotherapy, David was given the news in January of this year that there was no trace of cancer left in his body.

Since his news, David has worked tirelessly to raise money for cancer services by fundraising for ACT and has raised a staggering ÂŁ50,000 which will go to melanoma research and the ÂŁ14 million public appeal to build the new Cambridge Cancer Research Hospital on the Cambridge Biomedical Campus by 2029.

Explaining why he felt the need to continue fundraising for cancer research, David said: “The chances are I wouldn’t be here today if it wasn’t for people researching and developing new drugs to fight cancer and I think the new cancer hospital planned for Cambridge is going to take that to another level.”

“For people going through cancer, my message would be, never give up hope. There is always hope and it is amazing what is being developed in terms of new cancer treatments.”

Joyce Cripps, our fundraiser from Bishop’s Stortford in East Hertfordshire, was nominated as regional fundraiser for Anglia East Region after spending over half her life fundraising for charities.

The retired carer and care manager, pictured here, started fundraising over 40 years ago after her daughter Julie’s primary school was damaged by fire. She went on to raise over £104,000 for various charities including Cancer Research, Marie Curie, The Willow Foundation which organizes special holidays for terminally ill patients and their families, local hospitals, Guide Dogs for the Blind, and The Little Princess Trust, which makes wigs for children with cancer.

However, it was after her daughter Julie underwent a lifesaving liver transplant at Addenbrooke’s six years ago that Joyce pledged to dedicate all her fundraising to liver transplant research by raising money for ACT.

Joyce’s fundraising total for Addenbrooke’s transplant services is set to top £25K by the end of this year which she has raised through tribute nights which she books throughout the year, organizing raffle donations and making all the room and table decorations by hand herself.

As part of her nomination, Joyce was filmed with her husband, John, and daughter Julie visiting the transplant unit to meet Andrew Butler, the surgeon who performed Julie’s lifesaving transplant.

Some of Joyce’s money has already been used to refurbish two staff and patient rooms in the unit as well as fund a single use of the Liver Perfusion Machine, pictured above, which ACT supporters raised £250,000 to buy. As part of filming for the special, Joyce and her family got to see the machine – which mimics the body to ensure a liver’s functionality before transplant and allows surgeons to ‘test drive’ livers for suitability before transplanting them.

“As a family, words are not enough to express our gratitude to that wonderful team who saved Julie’s life. Realizing the difference my fundraising has made to other patients’ lives means this tireless work will continue to my days’ end!” Joyce said.

“I have agreed to ongoing monies raised be used for transplant research thus enabling many more lives being saved.  Had it not been for past research Julie’s story would have been very different.”

As well as David and Joyce, another one of our fundraisers featured on the ITV Anglia special. Pig farmer Nathan Lister, from Redgrave, drove the length of Britain in a bright pink Citroen Picasso – referred to as his ‘Pigasso’ after he transformed it into a fundraising pig, complete with snout, tail, ears and eye lashes.

Nathan was diagnosed with Hodgkin Lymphoma at 22 and underwent 12 intense rounds of chemotherapy at Addenbrooke’s Hospital. Now in remission, Nathan and his friends drove from John O’Groats in Scotland to Land’s End in Cornwall, raising more than ÂŁ12,000 for Addenbrooke’s Hospital through ACT and Cancer Research UK, who were interviewed on the show.

Congratulating David and Joyce, who were both nominated for their fundraising for ACT, our charity’s Chief Executive Shelly Thake said:

“We are extremely proud of all our fundraisers. Each and every one of them put in hours and hours of their own time to help make our hospitals even better. In David and Joyce’s case, both have worked tirelessly to raise funds that will go into research to benefit future patients.

“Both took it upon themselves to fundraise for our hospitals at what was a very stressful time in their life – David, when he was still undergoing immunotherapy treatment and Joyce, whilst her daughter was still recovering from a major, lifesaving operation. Not only that, but they continue to fundraise as well as share some of the more private and challenging moments of their life in order to help raise awareness and support others going through a difficult time themselves.”

“Whilst they didn’t get through to the Pride of Britain finals later this year, they did incredibly well to be nominated for ITV Anglia’s Regional Fundraiser of the Year. They should be incredibly proud of all the awareness and hard work they put into their fundraising so we would like to extend a huge congratulations to both of them and thank them for everything they do on behalf of ACT.”

This year’s 2024 Cambridge Dragon Boat Festival raises a staggering £35k for the new Cambridge Cancer Research Hospital

Posted on by sarah.rastrick@act4addenbrookes.org.uk

This year’s 2024 Cambridge Dragon Boat Festival blew fundraising expectations out of the water – with a staggering £35k raised for the new Cambridge Cancer Research Hospital (CCRH).

A total of 41 teams and over 600 competitors gathered along the riverbank at Fen Ditton for Saturday’s 18th Cambridge Dragon Boat Festival – paddling 30ft Dragon Boats up the river in glorious sunshine.

As well as the races, bankside entertainment brought the crowds in – with lion dances from the Cambridge Chinese Community and family-friendly entertainment provided by sponsors, Illumina (pictured below), with fun activities such as strawberry DNA extraction, dress like a scientist with a walk-through Cambridge DNA history, face painting and flag making.

We were there too – in a tent full of Addenbrooke’s Charitable Trust staff and volunteers, with donations to our raffle and hook a duck all helping to boost our £14 million public appeal for the new specialist cancer hospital.

Saturday’s electric event raised £35,000 and all funds will be used in support of the Cambridge Cancer Research Hospital (CCRH). The hospital, which will be built on the Cambridge Biomedical Campus by 2029, will bring together clinical and research expertise in a new, world-class hospital, designed in partnership with staff and patients. It will detect cancer earlier, treat it more precisely, and save more lives.

A special shout out to all the teams who competed to raise money for the new hospital – and to Cambridge 105 for supporting us on the day with live interviews and the Cambridge Independent who were taking photos on the day.

Teams travelled from outside the county to take part in Saturday’s Festival – with winners of the best dressed competition, Mosses Arc, travelling down from outside Chester to celebrate their friend Paul’s 50th birthday. Following a Noah’s Arc theme their outfits came two by two – with everything from flamingos to leopards, giant furry rats and chickens. We’re not sure how they managed to row in them – but they looked great!

Thank you also to the teams with multiple entries including TWI Ltd; Ring; AstraZeneca; Huawei Technologies; and the Railway Arms.

ACT’s Natasha Robertson, Corporate Partnerships Manager, hailed the festival a huge success and said: “It was such a fantastic day with an amazing atmosphere. It was lovely to meet all the teams and having the CCRH project team competing, as well as on their stand, meant that everyone who came – whether they were competing or coming to join in the fun – could see the direct impact they were having by helping to raise money for the new cancer hospital.

“We are absolutely delighted to have raised £35,000. It’s been our best festival yet!”

The overall winners were the Cosgrove Paddle Shifters

Lucy Morton, Executive Director from organisers NewWave Events, said: “The 2024 Cambridge Dragon Boat Festival was a complete success and the whole team at NewWave Events had a fantastic day with all the crews. The fundraising efforts resulted in a record-breaking amount being raised for ACT from this event and we’re eager to build on this further for 2025! Watch this space for more information about next year, with plans already starting we have lots of ideas and hopefully, we will be bringing the dragons back to the River Cam with a sell-out event for the 20th year!’

Mark Robinson, VP and General Manager, UK and Ireland, and Northern Europe, Illumina said: “lllumina had an incredible day as sponsors of the 2024 Cambridge Dragon Boat Festival to raise vital funds for Addenbrooke’s Charitable Trust to build a specialist cancer hospital in Cambridge. Seeing families, friends, and local businesses come together to support their teams provided an amazing atmosphere for the day and made it extra special.”

Elaine Chapman, Lead Advisory Nurse for CCRH, joined the CCRH project team in their boat and said: “We were absolutely delighted to take to the waters to raise money for Cambridge Cancer Research Hospital. It was my third time in a race crew and probably the best event yet!”

“We’d like to say a huge thank you to everyone who came out to support such an amazing cause which has led to an incredible £35K raised for our future facility, that is bringing world-leading research and clinical excellence together, to change the lives of cancer patients across the UK and beyond.”

“We’re involving patients and staff at every stage of our project, so it was incredibly fun and rewarding to have our patients with us racing on the River Cam for CCRH.”

ACT would like to extend a HUGE thank you to all the teams taking part on the day. We hope to see you return next year for an even bigger, better festival with funds from next year’s festival again going towards our £14 million public appeal to help build the new Cambridge Cancer Research Hospital.

Click here if you would like to donate to Cancer services at Addenbrooke’s and the new Cambridge Cancer Research Hospital.

Email our friendly fundraising team and find out what you can do to support our hospitals.

2024 Cambridge Dragon Boat Festival – ‘the biggest yet!’

Posted on by Danni Smith

The 2024 Cambridge Dragon Boat Festival looks set to be the biggest race yet – with over 40 teams and 600 competitors taking part to raise funds for the new Cambridge Cancer Research Hospital.

This year’s 18th Cambridge Dragon Boat Festival takes place on the River Cam at Fen Ditton on Saturday 7th September with teams of 10-15 paddling 30ft boats up the river with a drummer at the front beating time and a helm at the tail.

Races start at 10am, with a prize ceremony at the end of the day. Festival sponsor Illumina will be taking part on the day and with bankside entertainment, food vans and an on-site bar the event is guaranteed to be a fun-packed, family day out.

Lucy Morton, Executive Director at NewWave Events, said: “We’re on track for this year’s Cambridge Dragon Boat Festival – which is being held in the Chinese Year of the Dragon – to be the biggest one yet with record team entries! We have 41 team entries and over half the firms competing this year have taken part in previous years.”

“It is amazing to see this event growing year on year and incredibly rewarding to see how the fundraising efforts from all teams makes a difference to such a worthy cause. Each year, the event brings a fantastic atmosphere to the city and the energy on the day is amazing.”

“The races are really exhilarating and extremely rewarding to be a part of. For the teams that are competing it is a chance for them to be part of the incredible atmosphere. For spectators, it is a fantastic family day out.”

Friendly rivalry is a big part of what the event is about, but Lucy said it is the unpredictable element that makes the day fun for both competitors and spectators.

“Some of the strongest crews can be knocked out in the heats if they aren’t working together to paddle down the course so it’s very common for novice crews to take home the winner’s trophy on the day as long as they have the determination and team spirit to carry them through!”

All funds raised will help boost ACT’s ÂŁ14 million public appeal to help build the new specialist cancer hospital, whose pioneering research is expected to have a far-reaching impact not just regionally, but nationally and globally too. The Cambridge Cancer Research Hospital (CCRH) will be built on the Cambridge Biomedical Campus by 2029 and bring together clinical and research expertise in a new, world-class hospital, designed in partnership with staff and patients. The new hospital will detect cancer earlier, treat it more precisely, and save more lives.

Donna Lee-Willis, Head of Community Fundraising at Addenbrooke’s Charitable Trust, said: “We are so excited to be running this event again this year with our longstanding partners NewWave Events and this year’s sponsors, Illumina. Everyone who is there on the day – whether it be competitors or spectators – has a lot of fun and for us to be able to raise money for what is such a good cause makes everyone at ACT incredibly proud.”

Elaine Chapman, Lead Advisory Nurse for CCRH (pictured left), who is taking part herself as a member of the CCRH Project Team, said: “We are delighted this year’s Dragon Boat Festival is dedicating funds to the Cambridge Cancer Research Hospital project. This hospital will bring together the very best clinical care and research expertise in a specialist building that has considered the wellbeing of patients and staff. Thank you for supporting us, you are helping to change the story of cancer.”

Mark Robinson, VP and GM, UK and Ireland, Illumina says, “Illumina is proud to support this year’s Cambridge Dragon Boat Festival to aid ACT. This unique event is just one of the ways that our team here in Cambridge is giving back to communities in which we live and work, while at the same time having a lot of fun!”

Each team completes three heats, with the 12 fastest teams going through to the semis. Three semi-final winners and the fastest runner-up go through to the final. Each boat seats up to 10 paddlers and 1 drummer. The racecourse is a 200m straight course with each race lasting anywhere between 55 and 90 seconds, with times affected by water flow and weather conditions.

Trophies are awarded for 1st, 2nd, 3rd and 4th place as well as to the highest placed mixed crew (minimum of five female paddlers), best dressed crew and top charity fundraiser. Medals also go to the top three crews and the highest placed mixed crew.
The winner receives a bottle of bubbly, with the top charity fundraiser winning a punting experience courtesy of Let’s Go Punting.

Bankside entertainment and refreshments include traditional lion dance performances. There are also funfair style rides on the day, with sponsors Illumina hosting several fun activities including strawberry DNA extraction, dress like a scientist with a walk through Cambridge DNA history, a cake stand, face painting and flag making. Cambridge 105 is supporting the event, with live coverage and interviews, on the day.

Come along and support our teams on the day – and help boost our ÂŁ14 million appeal to see the new Cambridge Cancer Research Hospital built in the City by 2029.

For a taste of what to expect on the day, click on the video below.